Looking to learn what you need to know about the latest new products from PXG? These handy thumbnails will keep you up to date on the company's new releases across all club and ball catetgories.

Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 8.5% in the pre-market session after the company reported disappointing fourth-quarter results: its EPS missed significantly, and its full ...

What you need to know: A nine-piece set aimed at the beginning or launch-challenged golfer, PXG's Wildcat set is comprised of a driver, 5-wood, 6-hybrid, 7-iron through pitching wedge, sand wedge ...

PXG golf clubs have been on the market for over a decade, offering uber-premium golf equipment to many different player categories, specifically avid and better players. But the brand has never ...

What you should know: The PXG Wildcat package is a nine-club set designed for people who are new to golf. It blends technologies found in PXG’s premium clubs into a high-lofted driver ...

Wall Street analysts expect 10x Genomics (TXG) to post quarterly loss of $0.32 per share in its upcoming report, which indicates a year-over-year increase of 22%. Revenues are expected to be $158. ...

Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The company’s shares closed yesterday at $11.94.